H

Hartford Healthcare | Cancer Clinical Research Office

Research site
(Unclaimed)
Location
80 Seymour Street, P.O. Box 5037, Hartford, Connecticut, United States of America

Site insights

Top conditions

Top treatments

5Fluorouracil
Durvalumab
Azacitidine
Carboplatin
Cisplatin
Tamibarotene
Venetoclax
Nab-sirolimus

Parent organization

This site is a part of Hartford Healthcare

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 7 total trials
Locations recently updated

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

The purpose of the study is to evaluate the overall survival of participants treated with imetelstat compared to best available therapy with intermed...

Enrolling
Myelofibrosis
Drug: Imetelstat
Drug: Best Available Therapy (BAT)

The purpose of this study is to demonstrate the safety and effectiveness of the Cardioblate iRF and CryoFlex hand held devices for the treatment of n...

Enrolling
Persistent Atrial Fibrillation
Longstanding Persistent Atrial Fibrillation
Device: Cardioblate and Cryoflex hand held devices
Procedure: Surgical Ablation

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic in...

Active, not recruiting
Solid Tumor
Malignant Neoplasm
Drug: nab-sirolimus

Tamibarotene is being studied as a treatment for participants with a type of leukemia called acute myeloid leukemia, or AML for short. Tamibarotene i...

Enrolling
Acute Myeloid Leukemia
Drug: Azacitidine
Drug: Venetoclax

The purpose of this study is to find out whether treatment with the study drug durvalumab combined with a type of radiation therapy called stereotact...

Enrolling
Non-small Cell Lung Cancer Stage II
PD-L1 Gene Mutation
Radiation: Stereotactic Body Radiation Therapy
Drug: Durvalumab

Trial sponsors

Memorial Sloan Kettering Cancer Center (MSK) logo
A
G
Medtronic logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems